Nicole Nazareth practises intellectual property and regulatory law.
Nicole provides strategic advice to clients on the protection of their intellectual property, including trademarks, copyrights, patents, industrial designs, and trade secrets. She frequently assists with transactions involving intellectual property assets, and drafts agreements relating to the development, licensing and transfer of intellectual property. She also assists clients on all aspects and stages of their intellectual property disputes including providing pre-litigation opinions, drafting court filings, conducting discoveries, and representing clients at court hearings.
Nicole also assists clients with all aspects of regulatory compliance including food and beverage requirements, medical device and natural health product licensing, cosmetic notifications, advertising claims, and packaging and labelling compliance.
Nicole received her J.D. from the University of Toronto Faculty of Law, where she was an executive team member of the school’s Technology and Intellectual Property Group. While at law school, she earned a Certificate in Transnational Legal Studies from the Center for Transnational Legal Studies in London, England. Nicole also holds a degree in molecular biology and chemistry from the University of Toronto.
Nicole summered and articled with the firm before joining as an associate in 2020.
- Pfizer Canada Inc et al v. Janssen Inc, Janssen Biotech Inc, et al (T-396-13) - representing Pfizer in a patent impeachment and infringement action related to biologics for the treatment of rheumatoid arthritis.
- Rovi Guides, Inc. v. Videotron G.P. (T-921-17) - defending Videotron in an action for patent infringement.
- J.D., University of Toronto, 2019
- B.Sc. (Molecular Biology and Chemistry - High Distinction), University of Toronto, 2015
Memberships And Affiliations
- Law Society of Ontario
My latest insights
Health Canada publishes draft guidance for machine learning-enabled medical devices
6 September 2023 .6 minute read
Consultation on Health Canada’s transparency of clinical trials - draft guidance and...
2 March 2023 .1 minute read